process of obtaining the extract of the bark and the leaf of erythrina velutina for the production of dermocosmetic and / or pharmaceutical formulations with photochemotoxic activity
ALINE MICHAELE DE SAINT-GEORGE ALBUQUERQUE CHERON,ALLAN JONATHAN CHERNICHIARRO CORRÊA,BRUNO DE ALMEIDA ANDRADE,ELBA LÚCIA CAVALCANTI DE AMORIM,PATRÍCIA MARIA DA SILVA NERI
申请号：
BR102018070455
公开号：
BR102018070455A2
申请日:
2018.10.04
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
process of obtaining the extract of the bark and the leaf of erythrina velutina for the production of dermocosmetic and / or pharmaceutical formulations with photochemotective activity. the present invention deals with the process of obtaining standardized mulungu bark and leaf extracts (erythrina velutina willd., fabaceae； synonymies chirocalyx velutinus walp., corallodendron velutinum (willd.) kuntze, erythrina aculeatissima Desf., erythrina aurantiaca ridl and erythrina aurantiaca ridl. splendida diels), followed by incorporation in solid pharmaceutical formulations (films, powders, granules, tablets, pills, capsules and / or similar), semi-solid (emulsion, cream, gel, gel-cream and / or similar), liquid (solution, suspension and / or similar) and / or gaseous (aerosol, spray and / or similar), specifically applied as a photochemotective agent, for dermocosmetic and / or pharmaceutical purposes. the invention also refers to the use of standardized mulungu extracts, in association with other vegetable extract (s), synthetic drug (s) and / or excipient (s), in the same pharmaceutical formulations mentioned and with the same purpose, previously mentioned.processo de obtenção do extrato da casca e da folha de erythrina velutina para produção de formulações dermocosméticas e/ou farmacêuticas com atividade fotoquimioprotetora. a presente invenção trata do processo de obtenção de extratos padronizados da casca e folha do mulungu (erythrina velutina willd., fabaceae； sinonímias chirocalyx velutinus walp., corallodendron velutinum (willd.) kuntze, erythrina aculeatissima desf., erythrina aurantiaca ridl. e erythrina splendida diels), seguido por incorporação em formulações farmacêuticas sólidas (filmes, pós, granulados, comprimidos, drágeas, cápsulas e/ou similares), semissólidas (emulsão, creme, gel, gel-creme e/ou similares), líquidas (solução, suspensão e/ou similares) e/ou gasosas (aerossol, spray e/ou similares), especificamente aplicada como agente fotoquimioproteto
